Dallas, TX, United States of America

Edward J Walters

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Phase Pharmaceuticals LLC. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward J Walters. Retrieved from https://idiyas.com/inventor/edward-j-walters-p8crl869

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Allentown, NJ (US) (2022)
  • Dallas, TX (US) (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Edward J Walters: Innovator in Anaphylaxis Treatment

Introduction

Edward J Walters is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of medicine, particularly in the development of innovative treatments for anaphylaxis. With a total of 2 patents to his name, Walters is recognized for his dedication to improving patient care.

Latest Patents

Walters' latest patents focus on sublingual epinephrine tablets. These tablets provide a novel method for treating anaphylaxis, offering a convenient alternative to traditional epinephrine delivery methods. The patents also detail methods for concomitant therapy during cardiac events, treating hypoglycemia, and prophylaxis for immunotherapy, showcasing the versatility and potential impact of his inventions.

Career Highlights

Walters is currently associated with Phase Pharmaceuticals LLC, where he continues to innovate and develop new medical solutions. His work has garnered attention for its potential to enhance the quality of life for individuals at risk of severe allergic reactions.

Collaborations

Some of his notable coworkers include G Lynn Howard and Nicholas J Farina, who contribute to the collaborative environment at Phase Pharmaceuticals LLC. Their combined expertise fosters a culture of innovation and progress in the field.

Conclusion

Edward J Walters stands out as a key figure in the development of medical treatments for anaphylaxis. His innovative approach and dedication to improving patient outcomes make him a valuable contributor to the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…